In addition, statins also improve factors that are compromised in preeclampsia such as NO bioavailability, VEGF, and endothelial progenitor cells (Urbich and Dimmeler, 2005; Cudmore et al., 2007). The gene discussed is VEGFA; the disease is preeclampsia.